- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/547 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame spiro-condensed or forming part of bridged ring systems
Patent holdings for IPC class A61K 31/547
Total number of patents in this class: 84
10-year publication summary
|
6
|
3
|
3
|
2
|
4
|
2
|
3
|
7
|
5
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4425 |
7 |
| Merck Sharp & Dohme Corp. | 2183 |
5 |
| C4 Theraprutics, Inc. | 64 |
4 |
| Chronos Therapeutics Limited | 19 |
3 |
| Eli Lilly and Company | 4068 |
3 |
| Novartis AG | 10300 |
2 |
| Janssen Pharmaceutica N.V. | 3177 |
2 |
| Lawrence Livermore National Security, LLC | 1972 |
2 |
| City of Hope | 1027 |
2 |
| Elanco Animal Health Ireland Limited | 3 |
2 |
| Katholieke Universiteit Leuven | 1274 |
2 |
| Leidos Biomedical Research, Inc. | 41 |
2 |
| Revolution Medicines, Inc. | 328 |
2 |
| Aligos Therapeutics, Inc. | 161 |
2 |
| Theras, Inc. | 16 |
2 |
| Vividion Therapeutics, Inc. | 41 |
2 |
| Merck Sharp & Dohme LLC | 3728 |
2 |
| Pfizer Inc. | 3384 |
1 |
| FUJIFILM Corporation | 30458 |
1 |
| Takeda Pharmaceutical Company Limited | 2714 |
1 |
| Other owners | 35 |